D86.0 Sarcoidosis of lung

Name of the Condition

• Common Name(s): Sarcoidosis of lung
• Medical Term: Sarcoidosis of lung

Summary

Sarcoidosis of lung is a specific manifestation of sarcoidosis, a systemic inflammatory disease, where granulomas (clusters of inflammatory cells) form primarily in the lung tissue. This condition can cause respiratory symptoms and may affect lung function, though it can also be asymptomatic. Lung involvement is the most common presentation of sarcoidosis.

Causes

The exact cause of sarcoidosis of lung is unknown. It is believed to result from an abnormal immune response to an environmental trigger, such as an infection, allergen, or toxin, in genetically susceptible individuals. The immune system overreacts, leading to chronic inflammation and granuloma formation in the lungs.

Risk Factors

• Age: Most commonly diagnosed in individuals between 20 and 40 years old.
• Ethnicity: Higher prevalence in African-American and Northern European populations.
• Family History: A family history of sarcoidosis may increase risk.
• Gender: Slightly more common in females.

Symptoms

• Persistent dry cough and shortness of breath.
• Chest discomfort or pain.
• Fatigue and general malaise.
• Wheezing or difficulty breathing during exertion.
• In some cases, no symptoms (asymptomatic).

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as chest X-rays or CT scans), and laboratory tests. A definitive diagnosis may require a lung biopsy to confirm granuloma formation. Elevated serum angiotensin-converting enzyme (ACE) levels or abnormal lung function tests may also support the diagnosis.

Treatment Options

Treatment depends on the severity of symptoms and lung involvement. Mild cases may not require treatment and are monitored. For symptomatic or progressive disease, corticosteroids (e.g., prednisone) are commonly used to reduce inflammation. Other medications, such as immunosuppressants, may be considered in refractory cases. Oxygen therapy or pulmonary rehabilitation may help manage respiratory symptoms.

Prognosis and Follow-Up

The prognosis for sarcoidosis of lung varies. Many individuals experience mild or stable disease, while others may have progressive lung damage. Regular follow-up with a healthcare provider is important to monitor lung function, symptoms, and treatment response. Most cases do not lead to severe disability, but some may require long-term management.

Complications

• Progressive lung fibrosis or scarring, leading to reduced lung function.
• Pulmonary hypertension (high blood pressure in the lungs).
• Respiratory failure in severe cases.
• Recurrent respiratory infections.

Lifestyle & Prevention

• Avoid exposure to respiratory irritants (e.g., dust, chemicals) that may worsen symptoms.
• Quit smoking, as it can exacerbate lung inflammation.
• Maintain a healthy lifestyle with regular exercise to support overall lung health.
• Follow up with healthcare providers as recommended to monitor disease progression.

When to Seek Professional Help

Seek medical attention if you experience persistent cough, shortness of breath, chest pain, or unexplained fatigue. Early evaluation is important for managing symptoms and preventing complications. Prompt care is also advised if symptoms worsen or new respiratory issues develop.

Tips for Medical Coders

When coding for sarcoidosis of lung (ICD-10-CM code D86.0), ensure documentation supports the diagnosis, including clinical findings, imaging results, or biopsy confirmation. Code D86.0 is specific to lung involvement; if other organs are affected, additional codes may be required. Verify that the code aligns with the documented site of granuloma formation and any associated symptoms or complications.